Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2019 $ 14 $ 799,732 $ (1,672,891) $ (873,145)
Balance at the beginning (in shares) at Dec. 31, 2019 142,369      
Warrants issued   213,828   213,828
Share-based compensation   836,156   836,156
Net loss     (2,984,766) (2,984,766)
Balance at the end at Sep. 30, 2020 $ 14 1,849,716 (4,657,657) (2,807,927)
Balance at the end (in shares) at Sep. 30, 2020 142,369      
Balance at the beginning at Jun. 30, 2020 $ 14 1,655,069 (3,731,393) (2,076,310)
Balance at the beginning (in shares) at Jun. 30, 2020 142,369      
Share-based compensation   194,647   194,647
Net loss     (926,264) (926,264)
Balance at the end at Sep. 30, 2020 $ 14 1,849,716 (4,657,657) (2,807,927)
Balance at the end (in shares) at Sep. 30, 2020 142,369      
Balance at the beginning at Dec. 31, 2020 $ 14 2,044,362 (5,540,875) $ (3,496,499)
Balance at the beginning (in shares) at Dec. 31, 2020 142,369     142,369
Exchange of common shares of Marpai Health, Inc. $ (14)     $ (14)
Exchange of common shares of Marpai Health, Inc. (in shares) (142,369)      
Issuance of common shares of Marpai, Inc. $ 1,115 17,350,820   17,351,935
Issuance of common shares of Marpai, Inc. (in shares) 11,147,302      
Stock options exercised $ 2 47   49
Stock options exercised (in shares) 22,524      
Warrants issued   53,333   53,333
Share-based compensation   962,143   962,143
Net loss     (10,256,167) (10,256,167)
Balance at the end at Sep. 30, 2021 $ 1,117 20,410,705 (15,797,042) $ 4,614,780
Balance at the end (in shares) at Sep. 30, 2021 11,169,826     11,169,826
Balance at the beginning at Jun. 30, 2021 $ 1,115 20,154,521 (11,004,463) $ 9,151,173
Balance at the beginning (in shares) at Jun. 30, 2021 11,147,302      
Stock options exercised $ 2 47   49
Stock options exercised (in shares) 22,524      
Share-based compensation   256,137   256,137
Net loss     (4,792,579) (4,792,579)
Balance at the end at Sep. 30, 2021 $ 1,117 $ 20,410,705 $ (15,797,042) $ 4,614,780
Balance at the end (in shares) at Sep. 30, 2021 11,169,826     11,169,826